Arstasis Revenue and Competitors
Estimated Revenue & Valuation
- Arstasis's estimated annual revenue is currently $7M per year.
- Arstasis's estimated revenue per employee is $251,000
Employee Data
- Arstasis has 28 Employees.
- Arstasis grew their employee count by 0% last year.
Arstasis's People
Name | Title | Email/Phone |
---|
Arstasis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Arstasis?
Self-Sealing Access, Implant Free… Naturally. AXERA® Access seals securely using nothing but the femoral artery wall itself. AXERA® Access creates a long, shallow angle arteriotomy that delivers significant tissue-on-tissue overlap through the femoral artery wall. This creates a self-sealing opening that requires only minimal compression for rapid hemostasis and secure closure. Self-sealing access also provides excellent patient comfort and quick ambulation. And because AXERA® Access deposits no foreign material, it eliminates all implant related complications. Self-Sealing Access Benefits Demonstrated in RECITAL Study* - Significant decrease in manual compression time by half or more - Elevate bed to 45º within 15-30 minutes of hemostasis - Ambulate patients in 1 to 2 hours - No patient implant delivers excellent patient comfort and safety *AXERA 2 IFU, SECURE II and RECITAL clinical study summaries.
keywords:N/AN/A
Total Funding
28
Number of Employees
$7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arstasis News
... Competitive Landscape, Growth Factors, Top Venders and Forecast Till 2028 : Abbott, Cardinal Health, Arstasis, Cardiva Medical.
Global Arteriotomy Closure Devices Market 2022 Type, Application and Top Players Abbott, Abbott, Cardinal Health, Arstasis, Cardiva Medical.
It also looks at the key industry vendors that are now accessible. Abbott; Abbott; Cardinal Health; Arstasis; Cardiva Medical; Vasorum. It...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.8M | 28 | -3% | N/A |
#2 | $3.2M | 28 | 8% | N/A |
#3 | $6.6M | 29 | 0% | N/A |
#4 | $2.9M | 29 | -3% | N/A |
#5 | $2.8M | 29 | 12% | N/A |